Nova Scotia Health Authority

7 marketed · 2 in Phase 3

Quick facts

Founded2015

Marketed products

Phase 3 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Nova Scotia Health Authority

What are Nova Scotia Health Authority's marketed drugs?

Top marketed products include Aggressive Blood Pressure control, Chloroprocaine Injection, Controlled Release Morphine, Fleet Enema, Mepivacaine Injection, Prostagladin.

What is Nova Scotia Health Authority's pipeline?

Nova Scotia Health Authority has 2 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include acetaminophen plus codeine, acetaminophen plus ibuprofen.

When was Nova Scotia Health Authority founded?

Nova Scotia Health Authority was founded in 2015.

How many employees does Nova Scotia Health Authority have?

Nova Scotia Health Authority has approximately 7,194 employees.

Related